Samson Okello1, Michael Kanyesigye, Winnie R Muyindike, Brian Herb Annex, Peter W Hunt, Sebastien Haneuse, Mark Jacob Siedner. 1. aDepartment of Internal Medicine bImmune Suppression Syndrome Clinic, Mbarara Regional Referral Hospital, Mbarara, Uganda cThe Robert M. Berne Cardiovascular Research Center & Division of Cardiovascular Medicine, Department of Medicine, University of Virginia, Charlottesville, Virginia dDivision of HIV/AIDS, Department of Medicine, University of California, San Francisco, California eDepartment of Epidemiology fDepartment of Biostatistics, Harvard T.H Chan School of Public Health gDepartment of Medicine and Center for Global Health, Massachusetts General Hospital hHarvard Medical School, Boston, Massachusetts, USA.
Abstract
OBJECTIVE: The successful scale-up of antiretroviral therapy (ART) in sub-Saharan Africa has led to increasing life expectancy, and thus increased risk of hypertension. We aimed to describe the incidence and predictors of hypertension in HIV patients receiving ART at a publicly funded clinic in rural Uganda. METHODS: We abstracted data from medical records of adult patients who initiated ART at an HIV clinic in south-western Uganda during 2010-2012. We defined hypertension as at least two consecutive clinical visits, with a SBP at least 140 mmHg and/or SBP of at least 90 mmHg, or prescription for an antihypertensive medication. We calculated the incidence of hypertension and fit multivariable Cox proportional-hazards models to identify predictors of hypertension. RESULTS: A total of 3389 patients initiated ART without a prior diagnosis of hypertension during the observation period. Over 3990 person-years of follow-up, 445 patients developed hypertension, for a crude incidence of 111.5/1000 (95% confidence interval 101.9-121.7) person-years. Rates were highest among men aged at least 40 years (158.8 per/1000 person-years) and lowest in women aged 30-39 years (80/1000 person-years). Lower CD4 cell count at ART initiation, as well as traditional risk factors including male sex, increasing age, and obesity, were independently associated with hypertension. CONCLUSION: We observed a high incidence of hypertension in HIV-infected persons on ART in rural Uganda, and increased risk with lower nadir CD4 cell counts. Our findings call for increased attention to screening of and treatment for hypertension, along with continued prioritization of early ART initiation.
OBJECTIVE: The successful scale-up of antiretroviral therapy (ART) in sub-Saharan Africa has led to increasing life expectancy, and thus increased risk of hypertension. We aimed to describe the incidence and predictors of hypertension in HIV patients receiving ART at a publicly funded clinic in rural Uganda. METHODS: We abstracted data from medical records of adult patients who initiated ART at an HIV clinic in south-western Uganda during 2010-2012. We defined hypertension as at least two consecutive clinical visits, with a SBP at least 140 mmHg and/or SBP of at least 90 mmHg, or prescription for an antihypertensive medication. We calculated the incidence of hypertension and fit multivariable Cox proportional-hazards models to identify predictors of hypertension. RESULTS: A total of 3389 patients initiated ART without a prior diagnosis of hypertension during the observation period. Over 3990 person-years of follow-up, 445 patients developed hypertension, for a crude incidence of 111.5/1000 (95% confidence interval 101.9-121.7) person-years. Rates were highest among men aged at least 40 years (158.8 per/1000 person-years) and lowest in women aged 30-39 years (80/1000 person-years). Lower CD4 cell count at ART initiation, as well as traditional risk factors including male sex, increasing age, and obesity, were independently associated with hypertension. CONCLUSION: We observed a high incidence of hypertension in HIV-infectedpersons on ART in rural Uganda, and increased risk with lower nadir CD4 cell counts. Our findings call for increased attention to screening of and treatment for hypertension, along with continued prioritization of early ART initiation.
Authors: Wendy S Post; Matthew Budoff; Lawrence Kingsley; Frank J Palella; Mallory D Witt; Xiuhong Li; Richard T George; Todd T Brown; Lisa P Jacobson Journal: Ann Intern Med Date: 2014-04-01 Impact factor: 25.391
Authors: Isabelle Mulazzi; Jean Pierre Cambou; Xavier Girerd; Robert Nicodeme; Bernard Chamontin; Jacques Amar Journal: J Am Soc Hypertens Date: 2009-04-01
Authors: Francesca J Torriani; Lauren Komarow; Robert A Parker; Bruno R Cotter; Judith S Currier; Michael P Dubé; Carl J Fichtenbaum; Mariana Gerschenson; Carol K C Mitchell; Robert L Murphy; Kathleen Squires; James H Stein Journal: J Am Coll Cardiol Date: 2008-08-12 Impact factor: 24.094
Authors: Katherine Krauskopf; Mark L Van Natta; Ronald P Danis; Sapna Gangaputra; Lori Ackatz; Adrienne Addessi; Alex D Federman; Andrea D Branch; Curtis L Meinert; Douglas A Jabs Journal: J Int Assoc Provid AIDS Care Date: 2013 Sep-Oct
Authors: Ingjerd W Manner; Marius Trøseid; Olav Oektedalen; Morten Baekken; Ingrid Os Journal: J Clin Hypertens (Greenwich) Date: 2012-10-26 Impact factor: 3.738
Authors: Anthony N Muiru; Prossy Bibangambah; Linda Hemphill; Ruth Sentongo; June-Ho Kim; Virginia A Triant; David R Bangsberg; Alexander C Tsai; Jeffrey N Martin; Jessica E Haberer; Yap Boum; Jorge Plutzky; Peter W Hunt; Samson Okello; Mark J Siedner Journal: J Acquir Immune Defic Syndr Date: 2018-08-01 Impact factor: 3.731
Authors: Yunan Xu; Xinguang Chen; Akemi Wijayabahu; Zhi Zhou; Bin Yu; Emma C Spencer; Robert L Cook Journal: Curr HIV Res Date: 2020 Impact factor: 1.581
Authors: Samson Okello; Stephen B Asiimwe; Michael Kanyesigye; Winnie R Muyindike; Yap Boum; Bosco B Mwebesa; Jessica E Haberer; Yong Huang; Kenneth Williams; Tricia H Burdo; Russell P Tracy; David R Bangsberg; A Rain Mocello; Jeffrey N Martin; Peter W Hunt; Mark J Siedner Journal: J Acquir Immune Defic Syndr Date: 2016-12-01 Impact factor: 3.731
Authors: Daniel Muyanja; Conrad Muzoora; Anthony Muyingo; Winnie Muyindike; Mark J Siedner Journal: AIDS Patient Care STDS Date: 2015-12-18 Impact factor: 5.078
Authors: Ashita S Batavia; Patrice Severe; Myung Hee Lee; Alexandra Apollon; Yuan Shan Zhu; Kathryn M Dupnik; Margaret L McNairy; Jean W Pape; Daniel W Fitzgerald; Robert N Peck Journal: J Hypertens Date: 2018-07 Impact factor: 4.844